After a notable pickup toward the end of last year, biopharma M&A and IPO activity have accelerated in 2026.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
How spread tightness requires a more thorough search for value, even among less loved sectors.
Discover how liquid alternatives, including trend following and long-short commodities, can help investors build more resilient portfolios.
Portfolio Manager Laura Foll explains why UK equities remain an overlooked source of both dividend income and capital growth, with low valuations, global exposure and company-specific opportunities offering potential upside.
Mid-cap growth offers mix of business models and drivers that can support portfolio diversification beyond AI.
The World AI Conference highlights emerging opportunities across China's AI ecosystem.
How asset-backed finance can offer a differentiated return stream within a balanced private credit allocation.
Why we believe investors should actively consider short-duration fixed income.
Exploring how fixed maturity bond portfolios have grown in popularity.
Geothermal’s potential as a resilient low-carbon energy system.
A look at the factors supporting markets outside the U.S. and where we are seeing opportunities.